InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Assets (2016 - 2026)

InflaRx's (IFRX) quarterly Assets came in at $194.0 million in Q2 2026, up 133.37% year-over-year from $83.1 million in Q2 2025, and up 238.95% quarter-over-quarter from $57.2 million in Q1 2026.

Analysis

InflaRx (IFRX) Assets (2016 - 2026) Analysis & Trends

InflaRx has disclosed Assets across 11 years of filings, most recently posting $194.0 million for Q2 2026.

  • In Q2 2026, Assets rose 133.37% year-over-year to $194.0 million; the TTM figure through Jun 2026 stood at $194.0 million (up 133.37% YoY), while the FY2025 annual figure was $62.4 million, down 23.2% from the prior year.
  • Assets came in at $194.0 million for Q2 2026 at InflaRx, up from $57.2 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $194.0 million in Q2 2026 to a low of $57.2 million in Q1 2026.
  • Average Assets over 5 years is $107.1 million, with a median of $102.3 million recorded in 2022.
  • Year-over-year, Assets plunged 37.91% in 2024 and jumped 133.37% in 2026.
  • Over 5 years, Assets stood at $104.5 million in 2022, then rose by 23.8% to $129.3 million in 2023, then tumbled by 37.19% to $81.2 million in 2024, then declined by 20.88% to $64.3 million in 2025, then jumped by 201.84% to $194.0 million in 2026.
  • Per Business Quant data, the three most recent Assets figures were $194.0 million in Q2 2026, $57.2 million in Q1 2026, and $64.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 10.03 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.31 Bn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 194.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194.01 Mn
Mar 31, 2026 57.24 Mn
Dec 31, 2025 64.27 Mn
Sep 30, 2025 76.17 Mn
Jun 30, 2025 83.13 Mn
Mar 31, 2025 91.51 Mn
Dec 31, 2024 81.23 Mn
Sep 30, 2024 87.51 Mn
Jun 30, 2024 100.19 Mn
Mar 31, 2024 116.34 Mn
Dec 31, 2023 129.34 Mn
Sep 30, 2023 140.96 Mn
Jun 30, 2023 144.79 Mn
Mar 31, 2023 92.64 Mn
Dec 31, 2022 104.47 Mn
Sep 30, 2022 112.04 Mn
Jun 30, 2022 122.32 Mn
Mar 31, 2022 129.16 Mn
Dec 31, 2021 143.16 Mn
Sep 30, 2021 152.57 Mn